Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.30
+0.32 (6.43%)
At close: Mar 5, 2026, 4:00 PM EST
5.21
-0.09 (-1.65%)
After-hours: Mar 5, 2026, 6:49 PM EST
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $414.07 million as of March 5, 2026. Its market cap has increased by 58.65% in one year.
Market Cap
414.07M
Enterprise Value
85.81M
1-Year Change
58.65%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $414.07M, a decrease of -78.63%. That is a compound annual growth rate of -25.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 414.07M | 48.46% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 437.08M |
| NovaBridge Biosciences | 419.66M |
| Entrada Therapeutics | 419.04M |
| Upstream Bio | 414.48M |
| Niagen Bioscience | 409.26M |
| DiaMedica Therapeutics | 406.66M |
| PureTech Health | 400.74M |
| Armata Pharmaceuticals | 399.02M |